Infants at Risk for Aluminum Toxicity with Unapproved Potassium Phosphates Drug Product
FDA is warning health care professionals and pharmacies to avoid using Hospira's unapproved potassium phosphates drug product in pediatric patients because the aluminum exposure from this product is unsafe for this population.